HEALTH IMPLICATIONS OF NANOTECHNOLOGY IN MEDICINE

被引:0
作者
Groshev, Anastasia [1 ]
Hirani, Anjali A. [2 ]
Grover, Aditya [2 ]
Pathak, Yashwant V. [2 ]
Sutariya, Vijaykumar B. [2 ]
机构
[1] Univ S Florida, Morsani Coll Med, USF Hlth, Tampa, FL USA
[2] Univ S Florida, Dept Pharmaceut Sci, USF Coll Pharm, Tampa, FL USA
关键词
Nanotechnology; Delivery systems; Nanotoxicology; Healthcare;
D O I
10.3727/194982414X14138187301696
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nanotechnology as an emerging field presents a substantial potential for improvement of life via novel technologies ranging from supercomputer hardware to alternative energy sources. It is estimated that the amount of patent literature grew by 150% from 2006 to 2011. According to the US Patent Collection, the number of patents since 1975 to date is over 4,000 with approximately 10% of those being in the medical field. The spectrum of the applications in the medical field is especially exciting, as nanotechnology allows for design of novel active pharmacological ingredients and drug delivery systems presenting potential solutions for penetration of physiological barriers, drug targeting, and regulating sensitive transcription pathways. The patents and intellectual property protection has led to tremendous growth and development of various areas of medicine, such as diagnostics, imaging, and medical devices. In healthcare, the goals of the nanotechnology include improvement of quality of life and minimizing risk of off-target effects of potent medications. To accomplish that, National Nanotechnology Initiative investments are estimated to be more than $1,600 million in 2012 with more than $100 million spent toward environmental health and safety. However, growth of nanotechnology in medicine is still slower compared to other areas, such as electronics, due to the special safety considerations and approval process though the Food and Drug Administration. This work is dedicated to discussion of the current nanotechnology advances and patents pertaining to medicine and their safety implications in healthcare.
引用
收藏
页码:233 / 248
页数:16
相关论文
共 51 条
[1]   Medical Device Regulation and Nanotechnologies: Determining the Role of Patient Safety Concerns in Policymaking [J].
Altenstetter, Christa .
LAW & POLICY, 2011, 33 (02) :227-255
[2]   Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging [J].
Bao, Gang ;
Mitragotri, Samir ;
Tong, Sheng .
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 15, 2013, 15 :253-282
[3]   Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders [J].
Carroll, Richard T. ;
Bhatia, Deepak ;
Geldenhuys, Werner ;
Bhatia, Ruchi ;
Miladore, Nicholas ;
Bishayee, Anupam ;
Sutariya, Vijaykumar .
JOURNAL OF DRUG TARGETING, 2010, 18 (09) :665-674
[4]  
Caruso J. P., POSTER NANOTECHNOLOG
[5]   Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies [J].
Chauhan, Vikash P. ;
Stylianopoulos, Triantafyllos ;
Boucher, Yves ;
Jain, Rakesh K. .
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 2, 2011, 2 :281-298
[6]   Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities [J].
Cheng, Zhiliang ;
Al Zaki, Ajlan ;
Hui, James Z. ;
Muzykantov, Vladimir R. ;
Tsourkas, Andrew .
SCIENCE, 2012, 338 (6109) :903-910
[7]   Public perceptions about nanotechnology: Risks, benefits and trust [J].
Cobb, MD ;
Macoubrie, J .
JOURNAL OF NANOPARTICLE RESEARCH, 2004, 6 (04) :395-405
[8]   Effects of surgical resection on the evolution of quality of life in newly diagnosed patients with glioblastoma: a report on 19 patients surviving to follow-up [J].
Daigle, Kathya ;
Fortin, David ;
Mathieu, David ;
Saint-Pierre, Arnaud B. ;
Pare, Francois-Michel ;
de la Sablonniere, Annie ;
Goffaux, Philippe .
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) :1307-1313
[9]   Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications [J].
Edelhauser, Henry F. ;
Rowe-Rendleman, Cheryl L. ;
Robinson, Michael R. ;
Dawson, Daniel G. ;
Chader, Gerald J. ;
Grossniklaus, Hans E. ;
Rittenhouse, Kay D. ;
Wilson, Clive G. ;
Weber, David A. ;
Kuppermann, Baruch D. ;
Csaky, Karl G. ;
Olsen, Timothy W. ;
Kompella, Uday B. ;
Holers, V. Michael ;
Hageman, Gregory S. ;
Gilger, Brian C. ;
Campochiaro, Peter A. ;
Whitcup, Scott M. ;
Wong, Wai T. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (11) :5403-5420
[10]   The big picture on nanomedicine: the state of investigational and approved nanomedicine products [J].
Etheridge, Michael L. ;
Campbell, Stephen A. ;
Erdman, Arthur G. ;
Haynes, Christy L. ;
Wolf, Susan M. ;
McCullough, Jeffrey .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (01) :1-14